Trends in the prescribing of psychotropic medications to preschoolers.
暂无分享,去创建一个
F. Lynch | M. Boles | D. Safer | S. dosReis | J. Zito | J. Gardner
[1] M. Riddle,et al. Critical review of tricyclic antidepressant use in children and adolescents. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[2] J. Swanson,et al. Combining methylphenidate and clonidine: a clinically sound medication option. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[3] S. Gortmaker,et al. Changing patterns of conditions among children receiving Supplemental Security Income disability benefits. , 1999, Archives of Pediatrics & Adolescent Medicine.
[4] C. Kappagoda,et al. Clonidine overdose in childhood: Implications of increased prescribing , 1998, Journal of paediatrics and child health.
[5] M. Rappley,et al. Diagnosis of ADHD and Treatment with Psychotropic Medications in Children Ages 1 To 3 Years , 1998 .
[6] L. Greenhill. The Use of Psychotropic Medication in Preschoolers: Indications, Safety, and Efficacy , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[7] B. Vitiello. Pediatric Psychopharmacology and the Interaction between Drugs and the Developing Brain , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[8] K. Minde. The Use of Psychotropic Medication in Preschoolers: Some Recent Developments , 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[9] A. Duncan,et al. Clonidine poisoning—an emerging problem: Epidemiology, clinical features, management and preventative strategies , 1998, Journal of paediatrics and child health.
[10] D A Zarin,et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. , 1998, JAMA.
[11] S. Speedie,et al. Prevalence variations in psychotropic treatment of children. , 1998, Journal of child and adolescent psychopharmacology.
[12] S. Bennett,et al. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. , 1998, Journal of child and adolescent psychopharmacology.
[13] C. Arpino,et al. Prescription of neuroleptics for children and adolescents in Italy. , 1998, Journal of child and adolescent psychopharmacology.
[14] P. Jensen,et al. Medication development and testing in children and adolescents. Current problems, future directions. , 1997, Archives of general psychiatry.
[15] J. Swanson,et al. Case study: adverse response to clonidine. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[16] D. Safer,et al. Increased methylphenidate usage for attention deficit disorder in the 1990s. , 1996, Pediatrics.
[17] B J Burns,et al. Outcomes of mental health care for children and adolescents: I. A comprehensive conceptual model. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[18] S. Zubrick,et al. National trends in the use of stimulant medication for attention deficit hyperactivity disorder , 1996, Journal of paediatrics and child health.
[19] J. Biederman,et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.
[20] C. Popper. Combining Methylphenidate and Clonidine: Pharmacologic Questions and News Reports about Sudden Death , 1995 .
[21] J. Swanson,et al. Clonidine in the Treatment of ADHD: Questions about Safety and Efficacy , 1995 .
[22] P. Jensen,et al. Design and methodology issues for clinical treatment trials in children and adolescents. Child and adolescent psychopharmacology: expanding the research base. , 1994, Psychopharmacology bulletin.
[23] P. Ahmann,et al. Placebo-controlled evaluation of Ritalin side effects. , 1993, Pediatrics.
[24] R. Brook,et al. Childhood enuresis: prevalence, perceived impact, and prescribed treatments. , 1986, Pediatrics.